AU4789297A - Method for the detection of compounds that modulate the effects of the obese (ob) protein - Google Patents

Method for the detection of compounds that modulate the effects of the obese (ob) protein

Info

Publication number
AU4789297A
AU4789297A AU47892/97A AU4789297A AU4789297A AU 4789297 A AU4789297 A AU 4789297A AU 47892/97 A AU47892/97 A AU 47892/97A AU 4789297 A AU4789297 A AU 4789297A AU 4789297 A AU4789297 A AU 4789297A
Authority
AU
Australia
Prior art keywords
obese
modulate
protein
compounds
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47892/97A
Inventor
Lee James Beeley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9622869.7A external-priority patent/GB9622869D0/en
Priority claimed from GBGB9622865.5A external-priority patent/GB9622865D0/en
Priority claimed from GBGB9622849.9A external-priority patent/GB9622849D0/en
Priority claimed from GBGB9622868.9A external-priority patent/GB9622868D0/en
Priority claimed from GBGB9622851.5A external-priority patent/GB9622851D0/en
Priority claimed from GBGB9622866.3A external-priority patent/GB9622866D0/en
Priority claimed from GBGB9622867.1A external-priority patent/GB9622867D0/en
Priority claimed from GBGB9622870.5A external-priority patent/GB9622870D0/en
Priority claimed from GBGB9622850.7A external-priority patent/GB9622850D0/en
Priority claimed from GBGB9622848.1A external-priority patent/GB9622848D0/en
Priority claimed from GBGB9622847.3A external-priority patent/GB9622847D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU4789297A publication Critical patent/AU4789297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cell Biology (AREA)
  • Obesity (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU47892/97A 1996-11-01 1997-10-30 Method for the detection of compounds that modulate the effects of the obese (ob) protein Abandoned AU4789297A (en)

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
GB9622866 1996-11-01
GB9622849 1996-11-01
GB9622851 1996-11-01
GBGB9622849.9A GB9622849D0 (en) 1996-11-01 1996-11-01 Novel method
GB9622865 1996-11-01
GBGB9622868.9A GB9622868D0 (en) 1996-11-01 1996-11-01 Novel method
GB9622870 1996-11-01
GB9622868 1996-11-01
GBGB9622851.5A GB9622851D0 (en) 1996-11-01 1996-11-01 Novel method
GB9622850 1996-11-01
GB9622848 1996-11-01
GBGB9622866.3A GB9622866D0 (en) 1996-11-01 1996-11-01 Novel method
GBGB9622869.7A GB9622869D0 (en) 1996-11-01 1996-11-01 Novel method
GBGB9622847.3A GB9622847D0 (en) 1996-11-01 1996-11-01 Novel method
GBGB9622865.5A GB9622865D0 (en) 1996-11-01 1996-11-01 Novel method
GB9622869 1996-11-01
GBGB9622848.1A GB9622848D0 (en) 1996-11-01 1996-11-01 Novel method
GBGB9622850.7A GB9622850D0 (en) 1996-11-01 1996-11-01 Novel method
GB9622847 1996-11-01
GB9622867 1996-11-01
GBGB9622870.5A GB9622870D0 (en) 1996-11-01 1996-11-01 Novel method
GBGB9622867.1A GB9622867D0 (en) 1996-11-01 1996-11-01 Novel method
PCT/GB1997/002988 WO1998020158A1 (en) 1996-11-01 1997-10-30 Method for the detection of compounds that modulate the effects of the obese (ob) protein

Publications (1)

Publication Number Publication Date
AU4789297A true AU4789297A (en) 1998-05-29

Family

ID=27581686

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47892/97A Abandoned AU4789297A (en) 1996-11-01 1997-10-30 Method for the detection of compounds that modulate the effects of the obese (ob) protein

Country Status (13)

Country Link
EP (1) EP0951564A1 (en)
JP (1) JP2001503982A (en)
KR (1) KR20000053007A (en)
AR (1) AR010262A1 (en)
AU (1) AU4789297A (en)
CA (1) CA2270431A1 (en)
CZ (1) CZ149999A3 (en)
IL (1) IL129685A0 (en)
NO (1) NO992107L (en)
NZ (1) NZ335489A (en)
PL (1) PL333187A1 (en)
TR (1) TR199900963T2 (en)
WO (1) WO1998020158A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293533B1 (en) * 1997-07-14 1999-03-01 Angeletti P Ist Richerche Bio METHOD FOR THE SELECTION OF MOLECULES ABLE TO MIMIC, INHIBIT OR ENHANCE THE EFFECTS OF THE INTERACTION BETWEEN LEPTIN AND CELLS THAT
GB9814199D0 (en) * 1998-06-30 1998-08-26 Univ Buckingham Novel method
CA2335107C (en) * 1998-07-28 2010-01-19 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Leptin-mediated gene-induction
GB9828087D0 (en) * 1998-12-18 1999-02-17 Smithkline Beecham Plc Novel method
AU8178401A (en) 2000-05-22 2001-12-03 Vlaams Interuniv Inst Biotech Receptor-based interaction trap
GB0019327D0 (en) * 2000-08-08 2000-09-27 Buchanan Baillie Hamilton Paul Slimming system
US7575878B2 (en) 2004-11-18 2009-08-18 Vib Vzw Methods of inhibiting leptin-induced signaling with fibronectin III domain antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643748A (en) * 1994-09-14 1997-07-01 Progenitor, Inc. HU-B1.219, a novel human hematopoietin receptor
EP0815230A2 (en) * 1995-03-20 1998-01-07 Ligand Pharmaceuticals, Inc. MODULATORS OF ob GENE AND SCREENING METHODS THEREFOR
US5712094A (en) * 1995-03-27 1998-01-27 Ligand Pharmaceuticals, Inc. Methods for detecting modulators of cytokine action
BR9608686A (en) * 1995-05-30 1999-07-06 Smithkline Beecham Method for detecting compounds that modulate the effects of obesoprotein
JP2000511406A (en) * 1996-04-22 2000-09-05 メルク エンド カンパニー インコーポレーテッド Leptin assay

Also Published As

Publication number Publication date
JP2001503982A (en) 2001-03-27
TR199900963T2 (en) 1999-08-23
CA2270431A1 (en) 1998-05-14
EP0951564A1 (en) 1999-10-27
NO992107D0 (en) 1999-04-30
KR20000053007A (en) 2000-08-25
IL129685A0 (en) 2000-02-29
PL333187A1 (en) 1999-11-22
NO992107L (en) 1999-06-30
NZ335489A (en) 2001-01-26
AR010262A1 (en) 2000-06-07
CZ149999A3 (en) 1999-10-13
WO1998020158A1 (en) 1998-05-14

Similar Documents

Publication Publication Date Title
AU4838097A (en) Apparatus for the treatment of specimens
AU5324996A (en) Protein kinase c inhibitors
AU6024196A (en) Inspection of edges
AU2609197A (en) Apparatus for determining powder flowability
AU8245898A (en) Apparatus for sanitary packing of used objects
AU2496197A (en) Method for the detection of creatinine
AU1501697A (en) Improved method for the detection of protein
HUP9801744A3 (en) Method for the detection of compounds that modulate the effects of the obese protein
AU3228797A (en) Method of detecting gynecological carcinomas
AU4403197A (en) System for inspection of pipelines
AU5732596A (en) Apparatus for facilitating the detachment of an element from an object
AU6708796A (en) An apparatus for drying hard floors
AU4789297A (en) Method for the detection of compounds that modulate the effects of the obese (ob) protein
GB9603619D0 (en) Procedure for gearbox-type determination
AU5231398A (en) Apparatus for the analysis of liquid
AU2250897A (en) Sealing apparatus
AU4994399A (en) System for testing properties of materials
AU1055997A (en) Luminescent probes for protein detection
AU6104994A (en) Apparatus for the quantitative determination of particulate analytes
AU7217394A (en) Method for imaging an atomic-level of semiconductor
AU7506896A (en) Method for the simultaneous detection of polygenes
AU2545697A (en) Novel uses of phospholipase c inhibitors
HUP0000034A3 (en) Method for the detection of compounds that modulate the effects of the obese (ob)protein
AU5062198A (en) Method of imaging
AU6990296A (en) Method for diagnosis of ovarian dysgenesis

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted